netFormulary NHS
North Staffordshire Joint Formulary
North Staffordshire Clinical Commissioning Group
Stoke-on-Trent Clinical Commissioning Group
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Section
Notes:

For the most up to date list of agents funded by the Cancer Drugs Fund, please see Cancer Drug Fund List

The list should be read in conjunction with Appraisal and Funding of Cancer Drugs from July 2016 (including the new Cancer Drugs Fund).
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
08.01 Cytotoxic drugs (0,0)
08.01.01 Alkylating drugs (3,0)
08.01.02 Anthracyclines and other cytotoxic antibiotics (1,0)
08.01.03 Antimetabolites (8,0)
08.01.04 Vinca alkaloids and etoposide (0,0)
08.01.05 Other antineoplastic drugs (81,0)
08.02 Drugs affecting the immune response (0,0)
Immunosuppressant therapy (0,0)
08.02.01 Antiproliferative immunosuppressants (4,0)
08.02.02 Corticosteroids and other immunosuppressants (6,0)
08.02.03 Anti-lymphocyte monoclonal antibodies (7,0)
08.02.04 Other immunomodulating drugs (18,0)
08.03 Sex hormones and hormone antagonists in malignant disease (0,0)
08.03.01 Oestrogens (1,0)
08.03.02 Progestogens (2,0)
08.03.03 Androgens (0,0)
08.03.04 Hormone antagonists (0,0)
08.03.04.01 Breast cancer (6,0)
08.03.04.02 Prostate cancer and gonadorelin analogues (0,0)
Gonadorelin analogues (4,0)
Anti-androgens (6,0)
08.03.04.03 Somatostatin analogues (5,0)
netFormulary